
NantHealth, Inc.
- Jurisdiction
United States - LEI
549300Z86EF5CSQMW346 - ISIN
US6301041074 (NH )- Sectors
Scores
- Fair value (Benjamin Graham formula)
- N/A
- Financial strength (Piotroski F-Value)
-
4
/ 9
- Fundamental strength relative to industry (Mohanram G-Value)
-
6
/ 7
Profile
NantHealth, Inc., together with its subsidiaries, operates as a healthcare IT company in the United States, Canada, and the United Kingdom. Read full profile
Fundamentals
- Net revenue
€54.82M - Gross margin
61.2% - EBIT
-€37.91M - EBIT margin
-69.1% - Net income
-€60.02M - Net margin
-109.5%
Statement period: - (published )
Stock price
Dividends
No dividend payouts
Analyst ratings
No analyst ratings available
Insider Transactions
No insider transactions in the last 90 days. View older insider transactions
Earnings Calls
Earnings Calls
Latest earnings call: November 6, 2022 (Q3 2022)